Upcoming annual appointments for worldwide cancer clinicians and researchers, gaining more and more attendees every year, the 11th edition of Immunotherapy Bridge and the 16th edition of Melanoma Bridge will be held in Naples (Italy) from November 30th to December 1st and from December 1st to 3rd, respectively.
The first session of Immunotherapy Bridge will be jointly organized with the Society for ImmunoTherapy of Cancer and dedicated to the Modulator of Tumor Immunity and Immunotherapy. An in depth analysis of the drivers of organ specific immune response, the novel drugs development, the actual landscape and future perspectives on the field of cancer vaccines and the neoadjuvant therapies across cancers will follow.
The scientific program of Melanoma Bridge will be dedicated to the most pressing of the unanswered questions, the translational research in melanoma and the most valuable emerging strategies.
Both Immunotherapy and Melanoma Bridge meetings will host a “Great Debate” session, where counterpoint views from leading experts on specific controversial clinical issues will be presented, discussed and evaluated by the audience.
Location: Royal Continental Hotel Naples, Italy
Key Dates
Abstract Submission Deadline: 5 October 2026
Abstract Decision Notification: 30 October 2026